Single‐pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin gemini study)
R Blank, J LaSalle, R Reeves, J Maroni… - The journal of …, 2005 - Wiley Online Library
The Gemini Study was a 14‐week, open‐label, noncomparative, office‐based, multicenter
trial to evaluate single‐pill therapy in the treatment of concomitant hypertension and …
trial to evaluate single‐pill therapy in the treatment of concomitant hypertension and …
A randomized, placebo‐controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 …
RA Preston, P Harvey, O Herfert… - The Journal of …, 2007 - Wiley Online Library
Guidelines stress the importance of the simultaneous management of multiple
cardiovascular risk factors. This can in part be achieved by coadministration of lipid …
cardiovascular risk factors. This can in part be achieved by coadministration of lipid …
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial
FH Messerli, GL Bakris, RD Ferrera… - The Journal of …, 2006 - Wiley Online Library
The AVALON study was a randomized, multicenter trial to assess the efficacy and safety of
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …
Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial
JM Flack, R Victor, K Watson, KC Ferdinand… - Mayo Clinic …, 2008 - Elsevier
OBJECTIVE To investigate the efficacy and safety of single-pill amlodipine/atorvastatin
therapy for the simultaneous treatment of hypertension (HTN) and dyslipidemia in African …
therapy for the simultaneous treatment of hypertension (HTN) and dyslipidemia in African …
Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study)
Abstract The Gemini-AALA (Australia, Asia, Latin America, Africa/Middle East) study
evaluated the efficacy and safety of single-pill amlodipine/atorvastatin (Caduet) for the …
evaluated the efficacy and safety of single-pill amlodipine/atorvastatin (Caduet) for the …
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an …
FDR Hobbs, G Gensini, GBJ Mancini… - International journal of …, 2006 - Elsevier
BACKGROUND: In order to prevent cardiovascular events, it is essential to effectively
manage overall risk of cardiovascular disease. However, despite guideline …
manage overall risk of cardiovascular disease. However, despite guideline …
Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease
JF Dorval, T Anderson, J Buithieu, S Chan… - The American journal of …, 2005 - Elsevier
The effects of combined atorvastatin and amlodipine on blood pressure (BP) and low-
density lipoprotein (LDL) cholesterol levels were investigated in 134 patients with …
density lipoprotein (LDL) cholesterol levels were investigated in 134 patients with …
Amlodipine/valsartan single-pill combination: a prospective, observational evaluation of the real-life safety and effectiveness in the routine treatment of hypertension
Y Karpov, N Dongre, A Vigdorchik, K Sastravaha - Advances in therapy, 2012 - Springer
Introduction As several international guidelines on hypertension have now recommended,
singlepill/fixed-dose combination antihypertensive therapies may be particularly beneficial …
singlepill/fixed-dose combination antihypertensive therapies may be particularly beneficial …
Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia
K McKeage, MAA Siddiqui - American journal of cardiovascular drugs, 2008 - Springer
Amlodipine/atorvastatin (Caduet®) is a once-daily fixed-dose combination of the
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …
Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension
JE Frampton, LJ Scott - American journal of cardiovascular drugs, 2009 - Springer
Single-pill combinations of the dihydropyridine calcium channel blocker (CCB) amlodipine
and the angiotensin II receptor blocker valsartan (amlodipine/valsartan)[Exforge®] are …
and the angiotensin II receptor blocker valsartan (amlodipine/valsartan)[Exforge®] are …